ATAI Life Sciences (ATAI) Price & Analysis

Compare

1,657 Followers

ATAI Stock Chart & Stats

Day’s Range― - ―

52-Week Range$1.03 - $5.97

Previous CloseN/A

Volume1.44M

Average Volume (3M)5.80M

Market Cap

$1.13B

Enterprise Value$343.93M

Total Cash (Recent Filing)$95.94M

Total Debt (Recent Filing)$9.22M

Price to Earnings (P/E)―

Beta1.32

Next Earnings

Nov 18, 2025

EPS Estimate

-0.11

Last Dividend Ex-Date

Aug 27, 2018

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.14

Shares Outstanding214,338,330

10 Day Avg. Volume7,159,604

30 Day Avg. Volume5,801,359

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.30

Enterprise Value/Revenue148.95

Enterprise Value/Gross Profit148.95

Enterprise Value/Ebitda-2.97

Forecast

1Y Price Target

$11.00

Price Target Upside108.73% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering7

Bulls Say, Bears Say

Bulls Say

Financial PerformanceThe concurrent private placement raised $30M in gross proceeds, providing additional financial strength to Atai.

Merger And AcquisitionThe merger with Beckley Psytech is seen as a significant positive for Atai, integrating advanced short-acting psychedelic programs into the company.

Product DevelopmentBPL-003 is an intranasal program partially owned by Atai, aiming to be the first candidate to market for the chemical, with promising development for treatment-resistant depression and alcohol use disorder.

Bears Say

Business RisksThere are risks such as clinical development, competitor presence, and regulatory challenges that could impact the company's success.

Financial RisksThe need for annual equity raises from 2026 to 2029 may lead to shareholder dilution.

ATAI Life Sciences News

Atai Life Sciences files automatic mixed securities shelf

17:30 EDT Atai Life Sciences (ATAI) files automatic mixed securities shelf Published first on TheFly – the ultimate...

1m ago

ATAI

Atai Life Sciences files to sell 45.32M common shares for holders

17:30 EDT Atai Life Sciences (ATAI) files to sell 45.32M common shares for holders Published first on TheFly...

1m ago

ATAI

Psychedelic: Exclusive talk with ibogaine clinic Beond

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Tom Feegel, CEO and co-founder of...

4d ago

ATAI

CMND

3 Best Stocks to Buy Now, 9/23/2025, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below...

6d ago

ADVM

ATAI

Atai Life Sciences, Beckley Psytech to report Phase 2a data on BPL-003

atai Life Sciences (ATAI) and Beckley Psytech announced positive data from a proof-of-concept study investigating a two-dose induction...

6d ago

ATAI

Cathie Wood Pours $49M into Brera Holdings, Trims Roku and Tempus AI Stakes

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several notable portfolio adjustments on Thursday, September 18, according to the funds’ daily...

11d ago

TEM

ARCT

Atai Life Sciences awarded grant worth up to $11.4M from NIH

atai Life Sciences (ATAI) announced that it has been awarded a multi-year, milestone-driven grant worth up to $11.4...

11d ago

ATAI

Cathie Wood Invests $37M into Biotech Stocks, Trims Stake in KTOS, TEM, and ROKU Stocks

Ace hedge fund manager Cathie Wood’s ARK Invest ETFs (exchange-traded funds) reported several notable trades for Wednesday, September 17, 2025, highlighting...

11d ago

TEM

ARCT

ATAI Life Sciences to Acquire Beckley Psytech Shares

The latest update is out from ATAI Life Sciences ( ($ATAI) ). ATAI Life Sciences announced a share...

8m ago

ATAI

ATAI Life Sciences’ Promising Study on Treatment-Resistant Depression Boosts Buy Rating

Analyst Michael Okunewitch from Maxim Group maintained a Buy rating on ATAI Life Sciences and keeping the price...

5d ago

ATAI

ATAI Life Sciences: Promising Clinical Trials and Strategic Growth Opportunities Support Buy Rating

Analyst Sumant Kulkarni from Canaccord Genuity maintained a Buy rating on ATAI Life Sciences and keeping the price...

5d ago

ATAI

ATAI Life Sciences Announces Positive Phase 2a Study Results

ATAI Life Sciences ( ($ATAI) ) has issued an announcement. On September 23, 2025, ATAI Life Sciences and...

6d ago

ATAI

ATAI Life Sciences: Advancements in Psychedelic Therapies Justify Buy Rating

Analyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on ATAI Life Sciences and keeping the price...

17d ago

ATAI

Psychedelic: Exclusive talk with biopharma company Reunion Neuroscience

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Greg Mayes, President and Chief Executive...

1M ago

ATAI

CMND

ATAI FAQ

What was ATAI Life Sciences’s price range in the past 12 months?

ATAI Life Sciences lowest stock price was $1.03 and its highest was $5.96 in the past 12 months.

What is ATAI Life Sciences’s market cap?

ATAI Life Sciences’s market cap is $1.13B.

When is ATAI Life Sciences’s upcoming earnings report date?

ATAI Life Sciences’s upcoming earnings report date is Nov 18, 2025 which is in 50 days.

How were ATAI Life Sciences’s earnings last quarter?

ATAI Life Sciences released its earnings results on Aug 14, 2025. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of -$0.117 by -$0.023.

Is ATAI Life Sciences overvalued?

According to Wall Street analysts ATAI Life Sciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does ATAI Life Sciences pay dividends?

ATAI Life Sciences pays a Notavailable dividend of $6 which represents an annual dividend yield of N/A. See more information on ATAI Life Sciences dividends here

What is ATAI Life Sciences’s EPS estimate?

ATAI Life Sciences’s EPS estimate is -0.11.

How many shares outstanding does ATAI Life Sciences have?

ATAI Life Sciences has 214,338,330 shares outstanding.

What happened to ATAI Life Sciences’s price movement after its last earnings report?

ATAI Life Sciences reported an EPS of -$0.14 in its last earnings report, missing expectations of -$0.117. Following the earnings report the stock price went down -0.988%.

Which hedge fund is a major shareholder of ATAI Life Sciences?

Currently, no hedge funds are holding shares in ATAI

ATAI Life Sciences Stock Smart Score

Outperform

Fundamentals

Return on Equity

-62.43%

Trailing 12-Months

Asset Growth

-12.32%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

ATAI Life Sciences

ATAI Life Sciences is a biotechnology company focused on the development of innovative treatments for mental health disorders. Operating in the life sciences sector, ATAI aims to transform the mental health landscape by leveraging advanced therapeutics and psychedelic compounds. The company collaborates with various entities to create a diverse pipeline of products, including novel therapies for conditions such as depression, anxiety, and addiction.

ATAI Life Sciences (ATAI) Earnings & Revenues

Historic Earnings Reports

ATAI Stock 12 Month Forecast

Average Price Target

$11.00

▲(108.73% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","17":"$17","4.25":"$4.25","8.5":"$8.5","12.75":"$12.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$16.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$11.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$6.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,4.25,8.5,12.75,17],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.59,5.467692307692308,6.345384615384615,7.223076923076922,8.100769230769231,8.978461538461538,9.856153846153845,10.733846153846153,11.611538461538462,12.489230769230769,13.366923076923076,14.244615384615384,15.122307692307691,{"y":16,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.59,5.083076923076923,5.576153846153846,6.069230769230769,6.562307692307693,7.055384615384615,7.548461538461538,8.041538461538462,8.534615384615385,9.027692307692307,9.52076923076923,10.013846153846153,10.506923076923076,{"y":11,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.59,4.6984615384615385,4.806923076923077,4.915384615384616,5.023846153846153,5.132307692307692,5.240769230769231,5.349230769230769,5.457692307692308,5.5661538461538465,5.674615384615384,5.783076923076923,5.891538461538461,{"y":6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.42,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.3,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.08,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.69,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.33,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.55,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.72,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.24,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.47,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.49,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.71,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.17,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.59,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >